Istraživači
Janković, Radmila
Results 61-80 of 185
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2020 | Molecular diagnostics for cancer patients and high-risk individuals during the SARS-CoV-2 pandemic at the Institute for Oncology and Radiology of Serbia | Cavic, Milena R | Conference Paper | Mp. category will be shown later |
| 2020 | Practical handbook of pathology with photomicrographs![]() | Tomanović, Nada | Text book | Mp. category will be shown later |
| 2019 | EGFR mutation testing of advanced lung adenocarcinoma patients in Serbia – advantages and setbacks of liquid biopsy testing in developing countries![]() | Spasić, Jelena | Conference Paper | Mp. category will be shown later |
| 2019 | The predictive value of haematological parameters on the progression-free survival in advanced lung adenocarcinoma patients treated with tyrosine kinase inhibitors in Serbia![]() | Vera Jokic; Jelena Spasic | Conference Paper | Mp. category will be shown later |
| 2019 | Eleven years of RAS testing in colorectal cancer in Serbia: an institutional experience![]() | Mališić, Emina J. | Conference Paper | Mp. category will be shown later |
| 2019 | LungCARD - Report on worldwide research and clinical practices related to lung cancer![]() | Janković, Radmila | Article | 23M23 |
| 2019 | High expression of junctional adhesion molecule-A is associated with poor survival in patients with epithelial ovarian cancer![]() | Boljević, Ivana | Article | 22M22 |
| 2019 | Molecular prediction of chronic myeloid leukemia risk and resistance to imatinib.![]() | Jankovic, Radmila | Conference Paper | Mp. category will be shown later |
| 2019 | Small nucleotide polymorphism Arg72Pro of the tumor suppressor TP53 as a low-cost molecular predictor of chronic myeloid leukemia risk and resistance to imatinib![]() | Ana Urosevic; Tamara Filipovic; Aleksandra Stefanovic; Sinisa Radulovic | Conference Paper | Mp. category will be shown later |
| 2019 | The implementation of somatic BRCA1/2 testing in advanced ovarian cancer patients: Serbian experience![]() | Boljević, Ivana Ž. | Conference Paper | Mp. category will be shown later |
| 2019 | Tracking resistance to tyrosine kinase inhibitors (TKIs) by EGFR mutation testing from liquid biopsy of advanced lung adenocarcinoma patients![]() | Jokić V; Spasić Jelena | Conference Paper | Mp. category will be shown later |
| 2019 | Pharmacogenetics in clinical practice: how far have we come?![]() | Čavić, Milena R. | Conference Paper | Mp. category will be shown later |
| 2019 | Tumor characteristics, expressions of ERCC1, Bax, p53, IGF1R, Bcl2, Bcl2/Bax and prognostic factors for overall survival in patients with lung carcinoid![]() | Velinović, Marta; Janković, Radmila | Article | 23M23 |
| 2018 | Clinicopathological and genetic prognostic factors in lung neuroendocrine carcinoid tumors![]() | Čavić, Milena R. | Conference Paper | Mp. category will be shown later |
| 2018 | Molecular signature of response to preoperative radiotherapy in locally advanced breast cancer![]() | Tanić, Miljana | Article | 21M21 |
| 2018 | TP53 and DNA-repair gene polymorphisms genotyping as a low-cost lung adenocarcinoma screening tool.![]() | Čavić, Milena | Article | 21M21 |
| 2017 | P1.02-007 TP53 and DNA-Repair Gene Polymorphisms as Risk Factors for the Development of Advanced Lung Adenocarcinoma in Serbia![]() | Spasić, Jelena | Article | 21a+M21a+ |
| 2017 | Evaluation of the Functional Capacity of NK Cells of Melanoma Patients in an In Vitro Model of NK Cell Contact with K562 and FemX Tumor Cell Lines![]() | Konjević, Gordana M.; Vuletić, Ana M. | Article | 22M22 |
| 2017 | XRCC1 Arg399Gln and Rad51 G135C Gene Polymorphisms in Advanced Lung Adenocarcinoma in Serbia![]() | Spasić, Jelena | Conference Paper | Mp. category will be shown later |
| 2017 | Cytotoxic activity of Nepeta rtanjensis Diklić & Milojević essential oil and its mode of action![]() | Skorić, Marijana | Article | 21aM21a |
